Injection of stabilized hyaluronic acid-based gel of non-animal origin for the correction of nasolabial folds: Comparison with and without lidocaine

Dermatologic Surgery

Volumn 36, Issue SUPPL. 1, 2010, Pages 775-781

  Hedén, Per ^a   Fagrell, Dan ^b   Jernbeck, Jan ^a   Rylander, Richard ^c   Samuelson, Ulf ^a   Sellman, Gabriella ^c   Stark, Birgit ^c  

^a Akademikliniken ^*  (Sweden)

^b Göteborgs Plastikkirurgiska Center   (Sweden)

^c Sabbatsberg Hospital   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; LIDOCAINE; RESTYLANE PERLANE; UNCLASSIFIED DRUG;

ADULT; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GEL; HUMAN; HUMAN TISSUE; INJECTION SITE CONTUSION; INJECTION SITE PAIN; INJECTION SITE PRURITUS; INJECTION SITE REDNESS; INJECTION SITE SWELLING; INJECTION SITE TENDERNESS; MALE; MONOTHERAPY; NASOLABIAL FOLD; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUBCUTANEOUS TISSUE; TREATMENT DURATION; VISUAL ANALOG SCALE; WRINKLE; WRINKLE SEVERITY RATING SCALE;

EID: 77951279007     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01544.x     Document Type: Article

References (24)

1. Verpaele A, Strand A. Restylane SubQ, a non-animal stabilized hyaluronic acid gel for soft tissue augmentation of the mid- and lower face. Aesthet Surg J 2006 26 : S10 7.
2. American Society for Aesthetic Plastic Surgery. Cosmetic Surgery Statistics. Available at : http://www.surgery.org/media/statistics Accessed October 2009.
3. Andre P. Evaluation of the safety of a non-animal stabilized hyaluronic acid (NASHA - Q-Medical, Sweden) in European countries: a retrospective study from 1997 to 2001. J Eur Acad Dermatol Venereol 2004 18 : 422 425.
4. Carruthers A, Carey W, De Lorenzi C, et al. Randomized, double-blind comparison of the efficacy of two hyaluronic acid derivatives, Restylane Perlane and Hylaform, in the treatment of nasolabial folds. Dermatol Surg 2005 31 : 1591 1598.
5. Dover JS, Rubin MG, Bhatia AC. Review of the efficacy, durability, and safety data of two nonanimal stabilized hyaluronic acid fillers from a prospective, randomized, comparative, multicenter study. Dermatol Surg 2009 35 (Suppl 1) : 322 330.
6. Friedman PM, Mafong EA, Kauvar AN, et al. Safety data of injectable nonanimal stabilized hyaluronic acid gel for soft tissue augmentation. Dermatol Surg 2002 28 : 491 494.
7. Glogau RG, Kane MA. Effect of injection techniques on the rate of local adverse events in patients implanted with nonanimal hyaluronic acid gel dermal fillers. Dermatol Surg 2008 34 (Suppl 1) : S105 9.
8. Hamilton RG, Strobos J, Adkinson NF Jr. Immunogenicity studies of cosmetically administered nonanimal-stabilized hyaluronic acid particles. Dermatol Surg 2007 33 (Suppl 2) : S176 85.
9. Lindqvist C, Tveten S, Bondevik BE, et al. A randomized, evaluator-blind, multicenter comparison of the efficacy and tolerability of Perlane versus Zyplast in the correction of nasolabial folds. Plast Reconstr Surg 2005 115 : 282 289.
10. Matarasso SL, Carruthers JD, Jewell ML. Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). Plast Reconstr Surg 2006 117 : 3S 34S.
11. Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003 29 : 588 595.
12. Narins RS, Dayan SH, Brandt FS, et al. Persistence and improvement of nasolabial fold correction with nonanimal-stabilized hyaluronic acid 100,000 gel particles/mL filler on two retreatment schedules: results up to 18 months on two retreatment schedules. Dermatol Surg 2008 34 (Suppl 1) : S2 8.
13. Kamer FM, Churukian MM. Clinical use of injectable collagen. A three-year retrospective review. Arch Otolaryngol 1984 110 : 93 8.
14. Stegman SJ, Tromovitch TA. Implantation of collagen for depressed scars. J Dermatol Surg Oncol 1980 6 : 450 453.
15. Wahl G. European evaluation of a new hyaluronic acid filler incorporating lidocaine. J Cosmet Dermatol 2008 7 : 298 303.
16. Levy PM, De Bouille K, Rapsaldo H. Comparison of injection comfort of a new category of cohesive hyaluronic acid filler with preincorporated lidocaine and a hyaluronic acid filler alone. Dermatol Surg 2009 35 : 332 337.
17. Prescribing Information: Prevelle Silk. Available at:http://www.prevelle. com/prevelle-pids. pdf Accessed October 2009.
18. Day DJ, Littler CM, Swift RW, et al. The Wrinkle Severity Rating Scale: a validation study. Am J Clin Dermatol 2004 5 : 49 52.
19. Agerup B, Berg P, Akermark C. Non-animal stabilized hyaluronic acid: a new formulation for the treatment of osteoarthritis. BioDrugs 2005 19 : 23 30.
20. Benowitz NL, Meister W. Clinical pharmacokinetics of lignocaine. Clin Pharmacokinet 1978 3 : 177 201.
21. Rosenberg PH, Veering BT, Urmey WF. Maximum recommended doses of local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004 29 : 564 575.
22. Amsler E, Flahault A, Mathelier-Fusade P, et al. Evaluation of re-challenge in patients with suspected lidocaine allergy. Dermatology 2004 208 : 109 111.
23. Ball IA. Allergic reactions to lignocaine. Br Dent J 1999 186 : 224 226.
24. Campbell JR, Maestrello CL, Campbell RL. Allergic response to metabisulfite in lidocaine anesthetic solution. Anesth Prog 2001 48 : 21 6.